nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—CYP2D6—Niacin—atherosclerosis	0.216	0.3	CbGbCtD
Remoxipride—CYP2D6—Simvastatin—atherosclerosis	0.171	0.237	CbGbCtD
Remoxipride—CYP2D6—Pravastatin—atherosclerosis	0.167	0.232	CbGbCtD
Remoxipride—CYP2D6—Lovastatin—atherosclerosis	0.167	0.232	CbGbCtD
Remoxipride—HTR2A—arteriole—atherosclerosis	0.0118	0.287	CbGeAlD
Remoxipride—HTR2A—vein—atherosclerosis	0.00704	0.171	CbGeAlD
Remoxipride—HTR2A—hindlimb—atherosclerosis	0.00468	0.114	CbGeAlD
Remoxipride—HTR2A—appendage—atherosclerosis	0.00401	0.0974	CbGeAlD
Remoxipride—HTR2A—artery—atherosclerosis	0.00287	0.0696	CbGeAlD
Remoxipride—HTR2A—endothelium—atherosclerosis	0.00242	0.0588	CbGeAlD
Remoxipride—HTR2A—blood vessel—atherosclerosis	0.00223	0.0542	CbGeAlD
Remoxipride—SIGMAR1—adipose tissue—atherosclerosis	0.00165	0.04	CbGeAlD
Remoxipride—SIGMAR1—liver—atherosclerosis	0.00116	0.0281	CbGeAlD
Remoxipride—HTR2A—connective tissue—atherosclerosis	0.00114	0.0278	CbGeAlD
Remoxipride—HTR2A—cardiovascular system—atherosclerosis	0.000996	0.0242	CbGeAlD
Remoxipride—HTR2A—liver—atherosclerosis	0.000616	0.015	CbGeAlD
Remoxipride—CYP2D6—liver—atherosclerosis	0.000561	0.0136	CbGeAlD
Remoxipride—DRD3—Signaling by GPCR—F2—atherosclerosis	8.99e-05	0.000377	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EDN1—atherosclerosis	8.97e-05	0.000376	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PLG—atherosclerosis	8.96e-05	0.000376	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL5—atherosclerosis	8.9e-05	0.000374	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP7A1—atherosclerosis	8.85e-05	0.000371	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	8.82e-05	0.00037	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	8.75e-05	0.000368	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3CG—atherosclerosis	8.6e-05	0.000361	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SOCS3—atherosclerosis	8.48e-05	0.000356	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PRKCG—atherosclerosis	8.46e-05	0.000355	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VWF—atherosclerosis	8.42e-05	0.000354	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOC3—atherosclerosis	8.37e-05	0.000351	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	8.32e-05	0.000349	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LDLR—atherosclerosis	8.32e-05	0.000349	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VWF—atherosclerosis	8.29e-05	0.000348	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOC3—atherosclerosis	8.24e-05	0.000346	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KNG1—atherosclerosis	8.21e-05	0.000345	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AGT—atherosclerosis	8.2e-05	0.000344	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP3—atherosclerosis	8.19e-05	0.000344	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LDLR—atherosclerosis	8.19e-05	0.000344	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP27A1—atherosclerosis	8.18e-05	0.000343	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGTR1—atherosclerosis	8.17e-05	0.000343	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF2—atherosclerosis	8.16e-05	0.000343	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL3—atherosclerosis	8.13e-05	0.000341	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	8.06e-05	0.000339	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL2—atherosclerosis	8.01e-05	0.000336	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL3—atherosclerosis	7.99e-05	0.000336	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PLG—atherosclerosis	7.96e-05	0.000334	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOB—atherosclerosis	7.92e-05	0.000332	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL8—atherosclerosis	7.85e-05	0.00033	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EDN1—atherosclerosis	7.79e-05	0.000327	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NCF1—atherosclerosis	7.78e-05	0.000327	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	7.75e-05	0.000326	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA2—atherosclerosis	7.75e-05	0.000326	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALOX15—atherosclerosis	7.75e-05	0.000326	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	7.75e-05	0.000326	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL5—atherosclerosis	7.73e-05	0.000325	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCG5—atherosclerosis	7.66e-05	0.000322	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NCF1—atherosclerosis	7.66e-05	0.000321	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—F2—atherosclerosis	7.57e-05	0.000318	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LPL—atherosclerosis	7.56e-05	0.000317	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SOCS3—atherosclerosis	7.54e-05	0.000316	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—F2—atherosclerosis	7.45e-05	0.000313	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AGT—atherosclerosis	7.44e-05	0.000313	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPA—atherosclerosis	7.4e-05	0.000311	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PRKCG—atherosclerosis	7.35e-05	0.000309	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR2—atherosclerosis	7.35e-05	0.000309	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDNRA—atherosclerosis	7.35e-05	0.000309	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGT—atherosclerosis	7.32e-05	0.000307	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CYBA—atherosclerosis	7.32e-05	0.000307	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP3—atherosclerosis	7.28e-05	0.000306	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CG—atherosclerosis	7.25e-05	0.000304	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF2—atherosclerosis	7.25e-05	0.000304	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR2—atherosclerosis	7.23e-05	0.000304	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	7.23e-05	0.000304	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CYBA—atherosclerosis	7.2e-05	0.000302	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—BGN—atherosclerosis	7.16e-05	0.000301	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SPP1—atherosclerosis	7.16e-05	0.000301	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PARP1—atherosclerosis	7.16e-05	0.000301	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PLAT—atherosclerosis	7.16e-05	0.000301	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GHRL—atherosclerosis	7.16e-05	0.000301	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	7.13e-05	0.000299	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL8—atherosclerosis	7.13e-05	0.000299	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA5—atherosclerosis	7.09e-05	0.000298	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PLAT—atherosclerosis	7.05e-05	0.000296	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PARP1—atherosclerosis	7.05e-05	0.000296	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GHRL—atherosclerosis	7.05e-05	0.000296	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOB—atherosclerosis	7.03e-05	0.000295	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL8—atherosclerosis	6.97e-05	0.000293	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EDN1—atherosclerosis	6.92e-05	0.000291	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—F2—atherosclerosis	6.88e-05	0.000289	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL5—atherosclerosis	6.87e-05	0.000288	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	6.83e-05	0.000287	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—F2—atherosclerosis	6.77e-05	0.000284	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LPL—atherosclerosis	6.72e-05	0.000282	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PDGFB—atherosclerosis	6.63e-05	0.000278	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALOX5—atherosclerosis	6.59e-05	0.000277	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CG—atherosclerosis	6.58e-05	0.000276	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PRKCG—atherosclerosis	6.53e-05	0.000274	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	6.48e-05	0.000272	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGT—atherosclerosis	6.47e-05	0.000272	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SPP1—atherosclerosis	6.36e-05	0.000267	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOE—atherosclerosis	6.34e-05	0.000266	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LEP—atherosclerosis	6.34e-05	0.000266	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL8—atherosclerosis	6.33e-05	0.000266	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KNG1—atherosclerosis	6.29e-05	0.000264	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CAV1—atherosclerosis	6.28e-05	0.000264	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOA1—atherosclerosis	6.27e-05	0.000263	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGTR1—atherosclerosis	6.25e-05	0.000262	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KNG1—atherosclerosis	6.18e-05	0.00026	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	6.15e-05	0.000258	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL2—atherosclerosis	6.13e-05	0.000257	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PLG—atherosclerosis	6.09e-05	0.000256	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ESR1—atherosclerosis	6.05e-05	0.000254	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	6.03e-05	0.000253	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PLG—atherosclerosis	5.99e-05	0.000252	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—F2—atherosclerosis	5.98e-05	0.000251	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NAMPT—atherosclerosis	5.91e-05	0.000248	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PDGFB—atherosclerosis	5.89e-05	0.000247	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LIPC—atherosclerosis	5.88e-05	0.000247	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOC3—atherosclerosis	5.84e-05	0.000245	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LDLR—atherosclerosis	5.8e-05	0.000244	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SOCS3—atherosclerosis	5.77e-05	0.000242	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGT—atherosclerosis	5.75e-05	0.000241	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CG—atherosclerosis	5.72e-05	0.00024	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	5.67e-05	0.000238	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CETP—atherosclerosis	5.67e-05	0.000238	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LEP—atherosclerosis	5.63e-05	0.000236	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOE—atherosclerosis	5.63e-05	0.000236	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CAV1—atherosclerosis	5.58e-05	0.000234	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP3—atherosclerosis	5.57e-05	0.000234	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOA1—atherosclerosis	5.57e-05	0.000234	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF2—atherosclerosis	5.54e-05	0.000233	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP3—atherosclerosis	5.48e-05	0.00023	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MAPK3—atherosclerosis	5.48e-05	0.00023	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF2—atherosclerosis	5.46e-05	0.000229	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SCARB1—atherosclerosis	5.43e-05	0.000228	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INS—atherosclerosis	5.41e-05	0.000227	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOB—atherosclerosis	5.38e-05	0.000226	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ESR1—atherosclerosis	5.37e-05	0.000226	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	5.34e-05	0.000224	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL2—atherosclerosis	5.33e-05	0.000224	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—F2—atherosclerosis	5.31e-05	0.000223	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDN1—atherosclerosis	5.3e-05	0.000222	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOB—atherosclerosis	5.3e-05	0.000222	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL5—atherosclerosis	5.26e-05	0.000221	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	5.25e-05	0.00022	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1—atherosclerosis	5.24e-05	0.00022	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDN1—atherosclerosis	5.21e-05	0.000219	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL5—atherosclerosis	5.17e-05	0.000217	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LPL—atherosclerosis	5.14e-05	0.000216	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.13e-05	0.000215	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	5.08e-05	0.000213	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LPL—atherosclerosis	5.06e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PRKCG—atherosclerosis	5e-05	0.00021	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—atherosclerosis	4.97e-05	0.000209	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	4.92e-05	0.000206	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SPP1—atherosclerosis	4.87e-05	0.000204	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	4.87e-05	0.000204	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	4.85e-05	0.000203	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INS—atherosclerosis	4.81e-05	0.000202	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SPP1—atherosclerosis	4.79e-05	0.000201	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	4.77e-05	0.0002	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NOS3—atherosclerosis	4.75e-05	0.000199	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL2—atherosclerosis	4.73e-05	0.000199	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—atherosclerosis	4.65e-05	0.000195	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.57e-05	0.000192	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDGFB—atherosclerosis	4.5e-05	0.000189	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	4.43e-05	0.000186	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	4.42e-05	0.000185	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGT—atherosclerosis	4.4e-05	0.000185	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGT—atherosclerosis	4.33e-05	0.000182	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—atherosclerosis	4.31e-05	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOE—atherosclerosis	4.31e-05	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CAV1—atherosclerosis	4.27e-05	0.000179	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOA1—atherosclerosis	4.26e-05	0.000179	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—atherosclerosis	4.24e-05	0.000178	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOE—atherosclerosis	4.24e-05	0.000178	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOS3—atherosclerosis	4.22e-05	0.000177	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—atherosclerosis	4.21e-05	0.000177	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CAV1—atherosclerosis	4.2e-05	0.000176	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOA1—atherosclerosis	4.19e-05	0.000176	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ESR1—atherosclerosis	4.11e-05	0.000173	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—atherosclerosis	4.07e-05	0.000171	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—F2—atherosclerosis	4.06e-05	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ESR1—atherosclerosis	4.05e-05	0.00017	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—atherosclerosis	4.01e-05	0.000168	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—F2—atherosclerosis	4e-05	0.000168	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMOX1—atherosclerosis	3.92e-05	0.000165	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	3.89e-05	0.000163	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	3.83e-05	0.000161	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—atherosclerosis	3.81e-05	0.00016	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NFKB1—atherosclerosis	3.77e-05	0.000158	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOB—atherosclerosis	3.75e-05	0.000158	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—atherosclerosis	3.74e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	3.72e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK8—atherosclerosis	3.71e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—atherosclerosis	3.69e-05	0.000155	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INS—atherosclerosis	3.68e-05	0.000155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	3.66e-05	0.000154	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.65e-05	0.000153	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INS—atherosclerosis	3.62e-05	0.000152	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL2—atherosclerosis	3.62e-05	0.000152	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	3.61e-05	0.000152	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPL—atherosclerosis	3.59e-05	0.000151	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL2—atherosclerosis	3.56e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—atherosclerosis	3.56e-05	0.000149	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—atherosclerosis	3.56e-05	0.000149	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—atherosclerosis	3.5e-05	0.000147	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX1—atherosclerosis	3.5e-05	0.000147	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—atherosclerosis	3.42e-05	0.000144	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD36—atherosclerosis	3.41e-05	0.000143	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—atherosclerosis	3.39e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—atherosclerosis	3.38e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.38e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NFKB1—atherosclerosis	3.35e-05	0.000141	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	3.33e-05	0.00014	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK8—atherosclerosis	3.29e-05	0.000138	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—atherosclerosis	3.28e-05	0.000138	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK3—atherosclerosis	3.24e-05	0.000136	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.23e-05	0.000136	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.23e-05	0.000136	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOS3—atherosclerosis	3.18e-05	0.000133	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARA—atherosclerosis	3.17e-05	0.000133	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—atherosclerosis	3.14e-05	0.000132	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AGT—atherosclerosis	3.07e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—atherosclerosis	3.04e-05	0.000128	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—atherosclerosis	3.01e-05	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOE—atherosclerosis	3.01e-05	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CAV1—atherosclerosis	2.98e-05	0.000125	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA1—atherosclerosis	2.97e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK3—atherosclerosis	2.87e-05	0.000121	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.86e-05	0.00012	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.82e-05	0.000118	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—atherosclerosis	2.79e-05	0.000117	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.77e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.72e-05	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.72e-05	0.000114	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.71e-05	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2.68e-05	0.000112	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARG—atherosclerosis	2.62e-05	0.00011	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.59e-05	0.000109	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—INS—atherosclerosis	2.57e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.56e-05	0.000108	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.55e-05	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.52e-05	0.000106	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.52e-05	0.000106	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.51e-05	0.000105	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.48e-05	0.000104	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.47e-05	0.000104	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—atherosclerosis	2.37e-05	9.93e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—atherosclerosis	2.35e-05	9.88e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.33e-05	9.76e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.3e-05	9.67e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.29e-05	9.61e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.27e-05	9.51e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NOS3—atherosclerosis	2.25e-05	9.45e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.2e-05	9.24e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	9.16e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	2.16e-05	9.09e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.13e-05	8.96e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—atherosclerosis	2.1e-05	8.82e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	2.1e-05	8.82e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.06e-05	8.65e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—atherosclerosis	1.94e-05	8.14e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—atherosclerosis	1.61e-05	6.75e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.58e-05	6.64e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.48e-05	6.23e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.46e-05	6.13e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—atherosclerosis	1.03e-05	4.35e-05	CbGpPWpGaD
